Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–8 of 8 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05805605
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Biphenotypic Acute Leukemia, +54 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT05246345
- Conditions
- CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +18 more
- Locations
-
- CHU d'Amiens Amiens, France
- CHU de Besançon Besançon, France
- Hopital AVICENNE Bobigny, France
- CHU clermont-ferrand Clermont-Ferrand, France
NCT01750567
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
Completed
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT04191187
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +56 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT02722668
- Conditions
- Acute Leukemia, Acute Lymphoblastic Leukemia/Lymphoma, Acute Myeloid Leukemia, +74 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT02181478
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +35 more
- Locations
-
- Case Comprehensive Cancer Center Cleveland, Ohio, United States
Active, Not Recruiting
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT05479994
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
- Locations
-
- Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital Hefei, Anhui, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Beijing Jishuitan Hospital Beijing, Beijing Municipality, China
- Beijing Hospital Beijing, Beijing Municipality, China
Active, Not Recruiting
Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
NCT04624633
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States